No Detail Found!

Frequency of Nonalcoholic Fatty Liver Disease in General Medical Out Patients.

Author(s)
Saleem Iqbal Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Sheema Khan Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Muhammad Darwesh Iqbal Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Noorul Iman Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan
Abstract
Objectives: To determine the prevalence of Non Alcoholic Fatty Liver Disease (NAFLD) in patients seen in general medical outpatient department. Material and methods: This observational prospective study was conducted in General Medical Outpatient Department of Khyber Teaching Hospital Peshawar, from 4th April, 2017 to 4th July, 2017. A total of 2007, patients were reviewed, out of which, 436 patients had NAFLD, as suggested on ultrasound, were included in the study. Results: Out of 436 patients, 83.02%% were females, 61.46% were in the age range 40-60 years, 80.49% patients were obese as per BMI criterea, 54.81 % had hypertension, 35.77% had T2DM, 43.57% had Serum hypertriglyceridemia, 20.64% had serum hypercholestremia and 41.05 % had elevated Serum ALT level. Conclusion: Prevalence of NAFLD is increasing in females of age range 40 to 60 years, having higher frequency of obesity, hypertension, T2DM & serum hypertriglyceridemia.
Publication Details
Page(s) 202-206
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 26, Issue: 3, Year: 2018

Request the full text from PASTIC

References
BayardM.,HoltJ,BoroughsE., 2006.Nonalcoholic fatty liver disease,American Family Physician 73 1961 -68
RinellaME, 2015.Nonalcoholic Fatty Liver Disease, a systemic review,JAMA 313 2263 -73
KangH,JollK,JasonT,LauraFW,HariS., 2006.Metabolic syndrome is associated with greater histologic severity, higher carbohydrate and lower fat diet in patients with non-alcoholic fatty liver disease,Am J Gastroenterol 101 2247 -53
Angulo P. GI, 2007.Epidemiology: Nonalcoholic fatty liver disease,Aliment Pharmacol Ther 25 883 -9
Maxine A Papadakis , Stephen J Mcphee,Michael WRabow. Current Medical,Diagnosis, 2017.Treatment, Fifty sixth edition,Mc Graw Hil 56 697 -9
BruntEM, 2004.Non-alcoholic steatohepatitis,Semin Liver Dis 24 3 -20
FabbriniE,SullivanS,KleinS. Obesity, 2010.and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications,Hepatology 51 679 -89
2006.Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment:,Br J Diabetes Vasc Dis 6 251 -60
RectorRA,JohnPT,YangzhongW,IbdahJA, 2008.Non-alcoholic fatty liver disease and metabolic syndrome: an update,World J Gastroenterol 14 185 -92
QariFA,AiGhamdi A, 2005.Fatty liver in overweight and obese patients in Western part of Saudi Arabia: a study of sonological prevalence,Pak J Med Sci 21 143 -7
AdamLA,AnguloP, 2006.Treatment of non-alcoholic fatty liver disease,Postgrad Med J 82 315 -22
LuxmiRA,SattarRA,JamalA, 2008.Association of non-alcoholic fatty liver with type 2 diabetes mellitus,J Liaqat Uni Med Health 7 188 -93
MyersPR, 2009.Noninvasive diagnosis of nonalcoholic fatty liver disease,Ann Hepatol 8 S25 -S32
SaadehS,YounossiZM,RemerEM,GramlichT,OngJP,HurleyM,MullenKD,CooperJN,Sheridan MJ, 2002.The utility of radiological imaging in nonalcoholic fatty liver disease,Gastroenterology 123 745 -50
ParkSH,KimPN,KimKW,LeeSW,YoonSE,ParkSW, 2006.Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment,Radiology 239 105 -12
PaschosP,PaletasK., 2009.Non alcoholic fatty liver disease and metabolic syndrome,Hippokratia 13 9 -19
SaleemI., .Trends of Nonalcoholic Fatty liver Diseases patients in north of Pakistan,J Med Sci;25 344 -349
FanJG,SaibaraT,ChitturiS,KimBi,SungJJ, Chut19., -
taputti A, 2007.What are the risk factors and settings for non-alcoholic fatty liver disease in Asia Pacific,J Gastroenterol Hepatol 22 794 -800
TargerG,BertoliniL,PadovaniR,RodellaS,TessariR,ZenariL, 2007.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients,Diabetes Care 30 1212 -18
FerreiraVS,PemambucoRB,LopesE P,MoraisCN,RodriguesMC,ArudaMJ, 2010.Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus,Arq Bras Endocrinol Metab 54 362 -8
Preiss D., 2008.Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations,Clinical Science 115 141 -150
BellentaniS,BedogniG,MiglioliL,TiribelliC., 2004.The epidemiology of fatty liver,Eur J Gastroenterol Hepatol 16 1087 -93
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes,Hepatology 48 792 -8
CortrimHP,PraiseER,OliveiraCP,LeiteN,MartinelliA,GalliziJ, 2011.Non alcohol fatty liver disease in Brazil. Clinical and histological profile,Ann Hepatol 10 33 -7
LeiteNC,SallesGF,AraujoAL,Villela-NogueiraCA,CardosoCR, 2009.Prevalence and associated factors of non-alcoholic fatty liver disease in patients with Type2 diabetes mellitus,Liver Int 2 113 -9
0

Citations

0

Downloads

75

Views